Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ImmunoHorizons is Scopus-indexed (Q3, CiteScore 3.4), DOAJ. Published by American Association of Immunologists.
Checked against the index lists dated .
ISSN 2573-7732Verify ISSN ↗
Publisher: American Association of Immunologists
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 153 / 234 | 34th | Q3 |
| Immunology | 163 / 243 | 33rd | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q3, CiteScore 3.4.
ImmunoHorizons is Q3 in Immunology and Allergy (rank 153 of 234) and Q3 in Immunology (rank 163 of 243), by CiteScore 2025.
ImmunoHorizons is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3.4, quartile Q3, 34th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.912, quartile Q1, with an H-index of 28.
The publisher lists an article processing charge of about US$1,700 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ImmunoHorizons is published by American Association of Immunologists. Its ISSN is 2573-7732.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
ImmunoHorizons has an h-index of 35 and a 2-year mean of 2.14 citations per paper (OpenAlex). Its Scopus CiteScore is 3.4, quartile Q3. On 2-year citations it ranks #113 of 231 Scopus journals in Immunology and Allergy.
ImmunoHorizons published 83 papers in 2025; its busiest recent year was 2021 with 87. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from United States (75.8%), Canada (9.3%) and Australia (2.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.